Celtek Research History – celtek-bioscience.com

CB5005 Explained: Design, NF-κB Targeting, and the Preclinical Research Record

September 16, 2026 by Yao Lin

Blue-toned scientific illustration of a bead-like peptide chain crossing a curved cell membrane toward glowing linked molecular shapes beside a large cell interior, with vesicle-like and organelle-like forms in the background.

A chronological, evidence-led examination of CB5005, from its dual-function sequence and foundational patent to later glioma and lung-cancer delivery studies.

The History of Celtek Bioscience: From Early SBIR Research to CB5005

September 10, 2026 by Yao Lin

Stylized blue-toned illustration of a cell taking up a linked peptide-like chain in small vesicles, with the chain continuing toward a glowing nucleus; faint research papers, a lightbulb icon, books, glassware, and a culture dish appear above.

An evidence-led timeline of Celtek Bioscience, covering its reported 2002 formation, early NIH Phase I awards, apoptosis-related patent work, and later preclinical delivery research.